Trial Profile
Pharmacokinetcis of Tirabrutinib in combination with single dose rifampin and multiple dose rifampin in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Apr 2017
Price :
$35
*
At a glance
- Drugs Tirabrutinib (Primary) ; Rifampicin
- Indications B-cell lymphoma
- Focus Pharmacokinetics
- 05 Apr 2017 Results of pharmacodynamic biomarkers presented at the 108th Annual Meeting of the American Association for Cancer Research
- 05 Apr 2017 New trial record
- 18 Mar 2017 Results presented at the 118th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics